The present study assessed changes in epigenetic markers and pre- and postimplantation development in somatic cell nuclear transfer (SCNT) porcine embryos after treatment with the inhibitor of histone deacetylases (HDACi), Trichostatin A (TSA). Embryos were generated using in vitro matured oocytes and nuclei from either a male fetal fibroblast (FF) cell line or bone marrow cells (BMC) from three adult sows. After nuclear transfer, oocytes were either exposed or not to 10 ng/mL TSA for 10 h starting 1 h after cell fusion. Samples of one-cell stage and cleaved (two- to four-cell stage) embryos were fixed at 15 to 18 h or 46 to 48 h after cell fusion and immunocytochemically processed to detect histone H3 acetylation at lysine 14 (H3K14ac) or histone H3 dimethylation at lysine 9 (H3K9m2) using specific primary antibodies. TSA treatment increased the immunofluorescent signal for H3K14ac in cleaved embryos derived from both FF and BMC but did not affect H3K9m2. Development to the blastocyst stage was increased by TSA treatment (45.2 vs. 23.9%) in embryos produced from FF cells but not in those produced from BMC (30.6 vs. 27.4%). Cloned piglets were produced from both treatments when day 5 to 6 blastocyst-stage embryos derived from FF cells were transferred into the uterus of recipient females. Cloned piglets were also produced after the transfer of TSA-treated blastocysts derived from BMC of adult sows but not from control embryos. These findings suggest that the inhibition of histone deacetylases have similar effects on enhancing H3K14ac in SCNT embryos reconstructed from different cell types but the effect on in vitro and in vivo development seems to differ according to the nuclear donor cell type.

The objective of this study was to demonstrate that RNA interference (RNAi) and somatic cell nuclear transfer (SCNT) technologies can be used to attenuate the expression of specific genes in tissues of swine, a large animal species. Apolipoprotein E (apoE), a secreted glycoprotein known for its major role in lipid and lipoprotein metabolism and transport, was selected as the target gene for this study. Three synthetic small interfering RNAs (siRNA) targeting the porcine apoE mRNA were tested in porcine granulosa cells in primary culture and reduced apoE mRNA abundance ranging from 45–82% compared to control cells. The most effective sequence was selected for cloning into a short hairpin RNA (shRNA) expression vector under the control of RNA polymerase III (U6) promoter. Stably transfected fetal porcine fibroblast cells were generated and used to produce embryos with in vitro matured porcine oocytes, which were then transferred into the uterus of surrogate gilts. Seven live and one stillborn piglet were born from three gilts that became pregnant. Integration of the shRNA expression vector into the genome of clone piglets was confirmed by PCR and expression of the GFP transgene linked to the expression vector. Analysis showed that apoE protein levels in the liver and plasma of the clone pigs bearing the shRNA expression vector targeting the apoE mRNA was significantly reduced compared to control pigs cloned from non-transfected fibroblasts of the same cell line. These results demonstrate the feasibility of applying RNAi and SCNT technologies for introducing stable genetic modifications in somatic cells for eventual attenuation of gene expression in vivo in large animal species.

The effects of cycloheximide (CHX) treatment and the interval between fusion and activation on the development of pig nuclear transfer (NT) embryos constructed with enucleated oocytes and serum-starved granulosa/cumulus cells were examined. One group of couplets was fused and activated simultaneously (FAS) by a single electrical pulse (activation pulse). Another three groups of couplets were fused electricaly 1.5, 2.5 or 4.5 h before being subjected to the activation pulse (FBA). Each group was divided into two subgroups and incubated with or without CHX. The NT embryos treated with CHX showed a high and stable cleavage rate, regardless of the interval between fusion and activation; however, development to blastocysts was improved only when the NT embryos were subjected to FAS with CHX. These results indicate that CHX-sensitive events occurring shortly after FAS may be responsible for the development to blastocysts. Fusion pulse rarely activated M II oocytes, but rapidly dropped the p34cdc2 kinase activity in NT embryos. A pronucleus-like structure was observed 2-2.5 h after the activation pulse with CHX in NT embryos of both the FAS and FBA groups. Therefore, successive inactivation of M-phase promoting factor and cytostatic factor at a certain short interval may also play an important role in the development of NT embryos.

No abstract

Apolipoprotein E (apo E) is a known risk factor for developing premature atherosclerosis and Alzheimer’s syndrome. The aim of this study was to create a pig model with reduced apo E levels using RNA interference (RNAi) and somatic cell nuclear transfer (SCNT) technologies. Three synthetic small interfering RNA targeting the porcine apo E mRNA were designed, and the knockdown efficiency was assessed in cultured porcine granulosa cells by real-time PCR. The observed apo E knockdown efficiency ranged from 45 to 82% compared with control cells, indicating the targeted degradation of apoE mRNA.A small hairpin RNA (shRNA) expressing vector was constructed in PRNAT.U6.Neo (Genscript Corp., Piscataway, NJ, USA) based on the most effective apo E RNAi sequence under the control of polymerase III (U6) promoter, and then introduced into fetal porcine fibroblast cells. Clones were selected by neomycin treatment and green fluorescent protein (GFP) expression. SCNT was performed using IVM oocytes collected from prepubertal gilts. Oocyte maturation and activation and embryo culture were performed as previously described (Nascimento et al. 2009 Reprod. Domest. Anim. in press). Embryos were cultured in vitro for 5 to 6 days, briefly exposed to fluorescent light to confirm GFP expression, and then surgically transferred into the uterus of recipient gilts. The recipient gilts were synchronized by daily oral administration of altrenogest (20 mg day-1; Regu-Mate®, Intervet, Millsboro, MD, USA) for 12 or 13 days, followed by 1000 IU of eCG injected in the last day of altrenogest treatment and 500 IU of hCG 72 h later. Pregnancy diagnosis was performed by ultrasonography at Day 20 to 25 after embryo transfer, and parturition was induced by injecting PGF2? (10 mg of dinoprost tromethamine; Lutalyse®, Pfizer Canada Inc., Montreal, QC, Canada) at Day 115 of pregnancy. Rates of cleavage (74.7%) and development to the blastocyst stage (37.2%) were comparable with that of embryos reconstructed with nontransfected cells from the same cell line. A total of 309 embryos were transferred to 5 recipients, of which 3 became pregnant and farrowed. Seven live and 1 stillborn piglets were delivered naturally. The presence of the introduced plasmid and the expression of the GFP transgene tag were confirmed by PCR in placental and umbilical tissues of all the piglets. Six cloned pigs have survived after weaning and exhibit no obvious morphological defects. The status of apo E gene expression is currently under investigation. Supported by a NSERC Discovery Grant to VB.